Education
About Us
Working with TipRanks
Follow Us
Acarix AB (DE:7AC)
FRANKFURT:7AC
7AC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.01 - €0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€21.91M
Enterprise Value€260.24M
Total Cash (Recent Filing)kr53.99M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.23
Next Earnings
May 12, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,063,743,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)23.09
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
7AC FAQ
What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was €0.01 and its highest was €0.05 in the past 12 months.
What is Acarix AB’s market cap?
Acarix AB’s market cap is €21.91M.
When is Acarix AB’s upcoming earnings report date?
Acarix AB’s upcoming earnings report date is May 12, 2025 which is in 34 days.
How were Acarix AB’s earnings last quarter?
Acarix AB released its earnings results on Feb 13, 2025. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of €0 by >-€0.001.
Is Acarix AB overvalued?
According to Wall Street analysts Acarix AB’s price is currently Overvalued.
Does Acarix AB pay dividends?
Acarix AB does not currently pay dividends.
What is Acarix AB’s EPS estimate?
Acarix AB’s EPS estimate is 0.
How many shares outstanding does Acarix AB have?
Acarix AB has 1,063,743,800 shares outstanding.
What happened to Acarix AB’s price movement after its last earnings report?
Acarix AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of €0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Acarix AB?
Currently, no hedge funds are holding shares in DE:7AC
---
Company Description
Acarix AB
Acarix AB operates as a medical technology company which is engaged in developing diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Its main activities are to develop, produce and market a new cardiovascular diagnostic method and similar equipment for the same and related services. The company develops the CADScor acoustic device that is designed to be used by doctors to help assess patients' risk of coronary artery disease.
---
Technical Analysis
SciBase Holding AB
―
SpectraCure AB
―
Integrum AB Class B
―
Q-linea AB
―
BrainCool AB
―
---